Table 1 Baseline participant characteristics of the intervention group and the control group
|  | Intervention group (OncoActive, n = 249) | Control group (Usual care, n = 229) | P value |
|---|---|---|---|
Demographic characteristics | |||
 Age in years, mean (SD) | 66.55 (7.07) | 66.38 (8.21) | .81 |
 Gender, n (%) | .20 | ||
  Male | 212 (85.1) | 204 (89.1) | |
  Female | 37 (14.9) | 25 (10.9) | |
 Education, n (%) | .15 | ||
  Low | 109 (44.0) | 114 (50.0) | |
  Middle | 70 (28.2) | 47 (20.6) | |
  High | 69 (27.8) | 67 (29.4) | |
Cancer related characteristics | |||
 Type of cancer, n (%) | .34 | ||
  Prostate | 149 (59.8) | 143 (62.5) | |
  Colorectal | 100 (40.2) | 86 (37.5) | |
 Treatment phase, n (%) | .42 | ||
  During treatment | 19 (7.6) | 14 (6.1) | |
  After treatment | 230 (92.4) | 215 (93.9) | |
 Time since last treatment in months, mean (SD) | 5.64 (3.84) | 5.17 (3.49 | .16 |
 Type or treatment, n (%) | |||
  Surgery | 186 (81.2) | 192 (77.1) | .27 |
  Chemo | 41 (17.9) | 44 (17.7) | .95 |
  Radiotherapy | 63 (27.5) | 80 (32.1) | .27 |
  Hormonal treatment | 8 (3.5) | 10 (4.0) | .76 |
Health related characteristics | |||
 BMI, mean (SD) | 26.39 (3.38) | 26.74 (4.41) | .32 |
 Comorbidities yes, n (%) | 87 (35.2) | 86 (38.2) | .46 |
 Fatigue, mean (SD) | 58.95 (23.31) | 57.54 (24.25) | .52 |
 Anxiety, mean (SD) | 3.75 (3.22) | 3.37 (2.95) | .18 |
 Depression, mean (SD) | 3.54 (3.54) | 2.80 (2.91) | .01 |
 General HRQoL, mean (SD) | 80.01 (16.81) | 82.06 (14.15) | .15 |
 Physical Functioning, mean (SD) | 86.57 (14.39) | 86.58 (14.80) | .99 |
PA characteristics | |||
 MVPA SQUASH, mean (SD) | 798 (721) | 873 (764) | .27 |
 MVPA ActiGraph, mean (SD) | 271 (211) | 293 (230) | .30 |
 Days ≥30 min PA SQUASH, mean (SD) | 3.67 (2.05) | 3.86 (2.07) | .34 |
 Days ≥30 min PA ActiGraph, mean (SD) | 3.23 (2.46) | 3.38 (2.38) | .52 |
 PA intention, mean (SD) | 7.61 (1.35) | 7.74 (1.48) | .32 |